Detecting single nucleotide polymorphism using overlapping hydrolysis probes
US-9441268-B2 · Sep 13, 2016 · US
US9689026B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9689026-B2 |
| Application number | US-201615232070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 9, 2016 |
| Priority date | Nov 26, 2014 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for the rapid detection of the presence or absence of a SNP in a target nucleic acid in a sample are described. The methods can include performing an amplifying step, a hybridizing step utilizing a double stranded probe with two overlapping SNP specific hydrolysis probe sequences where one of the probe sequences can include a hairpin structure toward the 3′ end, and a detecting step. Furthermore, the double stranded SNP specific hydrolysis probes along with kits are provided that are designed for the detection of a SNP in a target nucleic acid.
Opening claim text (preview).
What is claimed: 1. A kit for detecting a single nucleotide polymorphism (SNP) that generates a mutant version of a target nucleic acid in a sample, comprising: a first primer comprising a first nucleic acid sequence and a second primer comprising a second nucleic acid sequence specific to produce an amplification product comprising a sense strand and an anti-sense strand of the target nucleic acid; and a double stranded probe comprising: a first mutant specific hydrolysis probe comprising a third nucleic acid sequence complementary to a region of the sense strand that contains the mutant generating SNP, the first mutant specific hydrolysis probe comprising a first interactive label and a second interactive label, a first 5′ end and a first 3′ end; and a second mutant specific hydrolysis probe comprising a fourth nucleic acid sequence complementary to a region of the anti-sense strand that contains the mutant generating SNP, the second mutant specific hydrolysis probe comprising a third interactive label and a fourth interactive label, a second 5′ end and a second 3′ end; wherein the target nucleic acid is the rpoB gene in Mycobacterium tuberculosis. 2. The kit of claim 1 , wherein the second mutant specific hydrolysis probe comprises a hairpin structure toward the second 3′ end, the hairpin structure comprising a region of non-naturally occurring nucleic acid sequence by changing or adding at least one non-naturally occurring nucleotide into a naturally occurring sequence. 3. The kit of claim 2 , wherein the first interactive label comprises a first donor fluorescent moiety at the first 5′ terminus, and the second interactive label comprises a first corresponding acceptor fluorescent moiety within no more than 8 nucleotides of the first donor fluorescent moiety on the first mutant specific hydrolysis probe, and wherein the third interactive label comprises a second donor fluorescent moiety at the second 5′ terminus, and the fourth interactive label comprises a second corresponding acceptor fluorescent moiety within no more than 8 nucleotides of the second donor fluorescent moiety on the second mutant specific hydrolysis probe. 4. The kit of claim 2 , wherein the first acceptor fluorescent moiety is a first quencher, and wherein the second acceptor fluorescent moiety is a second quencher. 5. The kit of claim 1 , further comprising a polymerase enzyme having 5′ to 3′ nuclease activity. 6. The kit of claim 1 , wherein the first and second nucleic acid sequences of the primers and/or the third and fourth nucleic acid sequences of the hydrolysis probes comprise at least one modified nucleotide. 7. The kit of claim 1 , wherein the first and second nucleic acid sequences of the primers and/or the third and fourth nucleic acid sequences of the hydrolysis probes have 40 or fewer nucleotides. 8. The kit of claim 1 , wherein the double stranded probe comprises a pair of oligonucleotides with nucleotide sequences selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2; SEQ ID NO:3 and SEQ ID NO:4; and SEQ ID NO:5 and SEQ ID NO:6. 9. A double stranded probe configured to detect a single nucleotide polymorphism (SNP) that generates a mutant version of a target nucleic acid, the double stranded probe comprising: a first mutant specific hydrolysis probe comprising a first nucleic acid sequence complementary to a mutant generating SNP-containing region of a sense strand of the target nucleic acid, the first mutant specific hydrolysis probe comprising a first interactive label and a second interactive label, a first 5′ end and a first 3′ end; and a second mutant specific hydrolysis probe comprising a second nucleic acid sequence complementary to a mutant generating containing region of an anti-sense strand of the target nucleic acid, the second SNP mutant specific hydrolysis probe comprising a third interactive label and a fourth interactive label, a second 5′ end and a second 3′ end; wherein the target nucleic acid is the rpoB gene in Mycobacterium tuberculosis. 10. The double stranded probe of claim 9 , wherein the second mutant specific hydrolysis probe comprises a hairpin structure toward the second 3′ end, the hairpin structure comprising a region of non-naturally occurring nucleic acid sequence by changing or adding at least one non-naturally occurring nucleotide into a naturally occurring sequence. 11. The double stranded probe of claim 10 , wherein the first interactive label comprises a first donor fluorescent moiety at the first 5′ terminus, and the second interactive label comprises a first corresponding acceptor fluorescent moiety within no more than 8 nucleotides of the first donor fluorescent moiety on the first mutant specific hydrolysis probe, and wherein the third interactive label comprises a second donor fluorescent moiety at the second 5′ terminus, and the fourth interactive label comprises a second corresponding acceptor fluorescent moiety within no more than 8 nucleotides of the second donor fluorescent moiety on the second mutant specific hydrolysis probe. 12. The double stranded probe of claim 10 , wherein the first acceptor fluorescent moiety is a first quencher, and wherein the second acceptor fluorescent moiety is a second quencher. 13. The double stranded probe of claim 9 , wherein first and second nucleic acid sequences of the hydrolysis probes comprise at least one modified nucleotide. 14. The double stranded probe of claim 9 , wherein the first and second nucleic acid sequences of the hydrolysis probes have 40 or fewer nucleotides. 15. The double stranded probe of claim 9 comprising a pair of oligonucleotides with nucleotide sequences selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2; SEQ ID NO:3 and SEQ ID NO:4; and SEQ ID NO:5 and SEQ ID NO:6.
characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title
for detection of mutation or polymorphism · CPC title
Polymerase chain reaction [PCR] · CPC title
involving interaction of two or more labels, e.g. resonant energy transfer · CPC title
Quantitative amplification · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.